Maravai Lifesciences Holdings Inc (MRVI)

R&D Expenses

$3.70M

Quarterly · Period ending: · USD

MRVI logo

MRVI R&D Expenses

Latest reported$3.70M
MRVI Quarterly R&D Expenses ($979.00K → $3.70M)
High-resolution chart · PNG

MRVI r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Maravai Lifesciences Holdings Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
3,702,000
3,889,000
3,788,000
9,770,000
4,882,000
4,888,000
4,561,000
4,344,000
5,284,000
5,032,000
4,594,000
4,347,000
4,194,000
4,145,000
5,011,000
5,389,000
4,274,000
3,695,000
9,173,000
1,946,000
1,929,000
2,160,000
2,092,000
1,868,000
1,600,000
3,744,000
979,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.